Morgan Stanley Pacific Biosciences Of California, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Morgan Stanley holds 3,892,542 shares of PACB stock, worth $6.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,892,542

Previous 3,079,756 26.39%

Holding current value

$6.85 Million

Previous $4.22 Million 56.84%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.2 - $2.17 $975,343 - $1.76 Million	812,786 Added 26.39%	3,892,542 $6.62 Million
Q2 2024 Oct 17, 2024	BUY	$1.36 - $3.65 $1.6 Million - $4.3 Million	1,176,905 Added 61.85%	3,079,756 $4.22 Million
Q2 2024 Aug 14, 2024	BUY	$1.36 - $3.65 $1.6 Million - $4.3 Million	1,176,905 Added 61.85%	3,079,756 $4.22 Million
Q1 2024 Oct 17, 2024	SELL	$3.52 - $9.59 $4.14 Million - $11.3 Million	-1,176,905 Reduced 38.21%	1,902,851 $7.14 Million
Q1 2024 Aug 16, 2024	SELL	$3.52 - $9.59 $32.4 Million - $88.3 Million	-9,206,731 Reduced 82.87%	1,902,851 $7.14 Million
Q1 2024 May 15, 2024	SELL	$3.52 - $9.59 $32.4 Million - $88.3 Million	-9,206,731 Reduced 82.87%	1,902,851 $7.14 Million
Q4 2023 Aug 16, 2024	BUY	$5.97 - $10.36 $47.9 Million - $83.2 Million	8,029,826 Added 260.73%	11,109,582 $109 Million
Q4 2023 Feb 13, 2024	BUY	$5.97 - $10.36 $52.7 Million - $91.4 Million	8,824,381 Added 386.15%	11,109,582 $109 Million
Q3 2023 Nov 15, 2023	BUY	$8.23 - $13.93 $4.52 Million - $7.66 Million	549,604 Added 31.67%	2,285,201 $19.1 Million
Q2 2023 Aug 14, 2023	SELL	$9.97 - $14.05 $3.18 Million - $4.48 Million	-318,931 Reduced 15.52%	1,735,597 $23.1 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $6.14 Million - $9.3 Million	773,836 Added 60.42%	2,054,528 $23.8 Million
Q4 2022 Feb 14, 2023	SELL	$5.67 - $11.2 $7.34 Million - $14.5 Million	-1,294,188 Reduced 50.26%	1,280,692 $10.5 Million
Q3 2022 Nov 14, 2022	SELL	$3.93 - $8.57 $2.52 Million - $5.5 Million	-641,686 Reduced 19.95%	2,574,880 $14.9 Million
Q2 2022 Oct 27, 2022	BUY	$4.02 - $10.43 $5.1 Million - $13.2 Million	1,267,924 Added 65.07%	3,216,566 $14.2 Million
Q2 2022 Aug 15, 2022	BUY	$4.02 - $10.43 $5.1 Million - $13.2 Million	1,267,924 Added 65.07%	3,216,566 $14.2 Million
Q1 2022 Oct 27, 2022	SELL	$8.43 - $20.9 $10.7 Million - $26.5 Million	-1,267,924 Reduced 39.42%	1,948,642 $17.7 Million
Q1 2022 May 13, 2022	BUY	$8.43 - $20.9 $7.09 Million - $17.6 Million	840,967 Added 75.92%	1,948,642 $17.7 Million
Q4 2021 Feb 14, 2022	SELL	$19.26 - $30.08 $8.45 Million - $13.2 Million	-438,882 Reduced 28.38%	1,107,675 $22.7 Million
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $38.4 Million - $54.2 Million	1,546,557 New	1,546,557 $39.5 Million

Others Institutions Holding PACB

# of Institutions

255

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $396M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account